# Study of Quadruple Therapy With Eltrombopag for Chronic Hepatitis C

> **NCT01821625** · PHASE2,PHASE3 · TERMINATED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 7 (actual)

## Conditions studied

- Thrombocytopenia
- Hepatitis C

## Interventions

- **DRUG:** Eltrombopag

## Key facts

- **NCT ID:** NCT01821625
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-04
- **Primary completion:** 2015-04
- **Final completion:** 2016-04
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Interferon use for hepatitis C plummeted, eliminating the need for study drug.
- **Last updated:** 2019-11-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01821625

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01821625, "Study of Quadruple Therapy With Eltrombopag for Chronic Hepatitis C". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT01821625. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*